« Back to Record
Dodion, P., Rozencweig, M., & Nicaise, C. (1982). Phase I trial of 9-hydroxy 2N-methyl ellipticinium (HME,NSC-264137) with a five-day schedule. Annual meeting of the American Association for Cancer Research. Proceedings, Vol. 23, 593.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/272212



